197 related articles for article (PubMed ID: 9267781)
21. Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion.
Quinn DI; Henshall SM; Brenner PC; Kooner R; Golovsky D; O'Neill GF; Turner JJ; Delprado W; Grygiel JJ; Sutherland RL; Stricker PD
Cancer; 2003 Apr; 97(8):1884-93. PubMed ID: 12673714
[TBL] [Abstract][Full Text] [Related]
22. [The digital rectal exam, prostate-specific antigen and transrectal echography in the diagnosis of prostatic cancer].
MartÃnez de Hurtado J; Chéchile Toniolo G; Villavicencio Mavrich H
Arch Esp Urol; 1995 Apr; 48(3):247-59. PubMed ID: 7538749
[TBL] [Abstract][Full Text] [Related]
23. Preoperative prediction of pathological tumor volume and stage in clinically localized prostate cancer: comparison of digital rectal examination, transrectal ultrasonography and magnetic resonance imaging.
McSherry SA; Levy F; Schiebler ML; Keefe B; Dent GA; Mohler JL
J Urol; 1991 Jul; 146(1):85-9. PubMed ID: 1711590
[TBL] [Abstract][Full Text] [Related]
24. The contribution of transrectal ultrasonography in the early diagnosis of prostate cancer.
Kostakopoulos A; Pikraminos D; Lissiotis P; Malachias G; Stavropoulos NI; Kontothanasis D
Acta Urol Belg; 1992; 60(1):57-63. PubMed ID: 1384290
[TBL] [Abstract][Full Text] [Related]
25. Nonpalpable cancer of the prostate: assessment with transrectal US.
Lee F; Bronson JP; Lee F; Torp-Pedersen ST; Siders DB; Thornbury JR; McHugh TA
Radiology; 1991 Jan; 178(1):197-9. PubMed ID: 1984304
[TBL] [Abstract][Full Text] [Related]
26. Stage T1c prostate cancer: perspectives on clinical management.
Smith JA
Semin Urol Oncol; 1995 Aug; 13(3):238-44. PubMed ID: 8521137
[TBL] [Abstract][Full Text] [Related]
27. Determination of local tumour extension in cases of carcinoma of the prostate.
Wolff JM; Borchers H; Jakse G
Arch Esp Urol; 1997 Jun; 50(5):546-53. PubMed ID: 9253209
[TBL] [Abstract][Full Text] [Related]
28. Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors.
Jack GS; Cookson MS; Coffey CS; Vader V; Roberts RL; Chang SS; Smith JA; Shappell SB
J Urol; 2002 Aug; 168(2):519-24. PubMed ID: 12131301
[TBL] [Abstract][Full Text] [Related]
29. The pathological features and prognosis of prostate cancer detectable with current diagnostic tests.
Ohori M; Wheeler TM; Dunn JK; Stamey TA; Scardino PT
J Urol; 1994 Nov; 152(5 Pt 2):1714-20. PubMed ID: 7523718
[TBL] [Abstract][Full Text] [Related]
30. Preoperative prediction of tumor heterogeneity and recurrence after radical prostatectomy for localized prostatic carcinoma with digital rectal, examination prostate specific antigen and the results of 6 systematic biopsies.
Huland H; Hammerer P; Henke RP; Huland E
J Urol; 1996 Apr; 155(4):1344-7. PubMed ID: 8632570
[TBL] [Abstract][Full Text] [Related]
31. Biopsy indication--a predictor of pathologic stage among men with preoperative serum PSA levels of 4.0 ng/mL or less and T1c disease.
Freedland SJ; Mangold LA; Epstein JI; Partin AW
Urology; 2004 May; 63(5):887-91. PubMed ID: 15134972
[TBL] [Abstract][Full Text] [Related]
32. Cancer detected incidental to simple prostatectomy (stage A1).
Epstein JI
J Cell Biochem Suppl; 1992; 16H():78-82. PubMed ID: 1289677
[TBL] [Abstract][Full Text] [Related]
33. Biologic aggressiveness of palpable and nonpalpable prostate cancer: assessment with endosonography.
Baran GW; Golin AL; Bergsma CJ; Stone TE; Wilson PR; Reichardt BA; Lobert PF; Locke CS
Radiology; 1991 Jan; 178(1):201-6. PubMed ID: 1984305
[TBL] [Abstract][Full Text] [Related]
34. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer.
Catalona WJ; Smith DS; Ratliff TL; Dodds KM; Coplen DE; Yuan JJ; Petros JA; Andriole GL
N Engl J Med; 1991 Apr; 324(17):1156-61. PubMed ID: 1707140
[TBL] [Abstract][Full Text] [Related]
35. Transrectal ultrasound and core biopsies for the diagnosis of prostate cancer. A study of pretreatment investigation strategy for patients with suspected prostate cancer.
Norberg M
Acta Radiol Suppl; 1994; 393():1-21. PubMed ID: 8184698
[TBL] [Abstract][Full Text] [Related]
36. [Puncture biopsy of the prostate].
Lechevallier E
Prog Urol; 1996; 6(4):507-18. PubMed ID: 8924925
[TBL] [Abstract][Full Text] [Related]
37. [Early diagnosis of prostatic carcinoma by random biopsies in 60 patients clinically negative but with PSA greater than 8.9 ng/ml].
Bianchi A; Bottanelli A; Baroni G; Rovellini P; Sciaraffia G; Toia G; Marcelli G
Arch Ital Urol Androl; 1997 Dec; 69(5):313-8. PubMed ID: 9477617
[TBL] [Abstract][Full Text] [Related]
38. Three-dimensional grayscale ultrasound: evaluation of prostate cancer compared with benign prostatic hyperplasia.
Sedelaar JP; van Roermund JG; van Leenders GL; Hulsbergen-van de Kaa CA; Wijkstra H; de la Rosette JJ
Urology; 2001 May; 57(5):914-20. PubMed ID: 11337294
[TBL] [Abstract][Full Text] [Related]
39. [Carcinoma of the prostate: correlation between local staging and systemic progression].
Rosi P; Marzi M; Mearini E; Bracarda S; Valli PP; Petroni PA; Porena M
Arch Ital Urol Androl; 1996 Dec; 68(5 Suppl):91-5. PubMed ID: 9162385
[TBL] [Abstract][Full Text] [Related]
40. Pathological characteristics and prognosis of nonpalpable and palpable prostate cancers with a Hybritech prostate specific antigen of 4 to 10 ng./ml.
Geary ES; Stamey TA
J Urol; 1996 Sep; 156(3):1056-8. PubMed ID: 8709306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
